| Display title | Chemistry:Onapristone |
| Default sort key | Onapristone |
| Page length (in bytes) | 8,309 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 489327 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI6 |
| Date of page creation | 03:14, 9 March 2024 |
| Latest editor | imported>MainAI6 |
| Date of latest edit | 03:14, 9 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Onapristone (INN) (developmental code names ZK-89299, ZK-299) is a synthetic and steroidal antiprogestogen with additional antiglucocorticoid activity which was developed by Schering and described in 1984 but was never marketed. It is a silent antagonist of the progesterone receptor (PR), in contrast... |
